Willow Biosciences Inc. provided earnings guidance for the year 2023. For the period, the company anticipates that revenue will accelerate during the second half of the year leading to Willow's continued confidence in its ability to post rather significant revenue growth for the full year coupled with reduced cash burn.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1 CAD | 0.00% | -4.76% | 0.00% |
1st Jan change | Capi. | |
---|---|---|
0.00% | 9.26M | |
+0.58% | 92.38B | |
-3.03% | 37.9B | |
-10.46% | 33.73B | |
+74.71% | 27.98B | |
-13.39% | 15.86B | |
-1.08% | 13.97B | |
-11.15% | 11.67B | |
+169.04% | 10.17B | |
-50.19% | 10.04B |
- Stock Market
- Equities
- WLLW Stock
- News Willow Biosciences Inc.
- Willow Biosciences Inc. Provides Earnings Guidance for the Year 2023